Literature DB >> 23359422

Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells.

Cary Fu1, Kevin C Ess.   

Abstract

Tuberous sclerosis complex (TSC) is a genetic disease characterized by multiorgan benign tumors as well as neurological manifestations. Epilepsy and autism are two of the more prevalent neurological complications and are usually severe. TSC is caused by mutations in either the TSC1 (encodes hamartin) or the TSC2 (encodes tuberin) genes with TSC2 mutations being associated with worse outcomes. Tuberin contains a highly conserved GTPase-activating protein (GAP) domain that indirectly inhibits mammalian target of rapamycin complex 1 (mTORC1). mTORC1 dysregulation is currently thought to cause much of the pathogenesis in TSC but mTORC1-independent mechanisms may also contribute. We generated a novel conditional allele of Tsc2 by flanking exons 36 and 37 with loxP sites. Mice homozygous for this knock-in Tsc2 allele are viable and fertile with normal appearing growth and development. Exposure to Cre recombinase then creates an in-frame deletion involving critical residues of the GAP domain. Homozygous conditional mutant mice generated using Emx1(Cre) have increased cortical mTORC1 signaling, severe developmental brain anomalies, seizures, and die within 3 weeks. We found that the normal levels of the mutant Tsc2 mRNA, though GAP-deficient tuberin protein, appear unstable and rapidly degraded. This novel animal model will allow further study of tuberin function including the requirement of the GAP domain for protein stability.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359422      PMCID: PMC3633697          DOI: 10.1002/dvg.22377

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  34 in total

1.  A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA.

Authors:  E C Lee; D Yu; J Martinez de Velasco; L Tessarollo; D A Swing; D L Court; N A Jenkins; N G Copeland
Journal:  Genomics       Date:  2001-04-01       Impact factor: 5.736

2.  Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.

Authors:  C Joinson; F J O'Callaghan; J P Osborne; C Martyn; T Harris; P F Bolton
Journal:  Psychol Med       Date:  2003-02       Impact factor: 7.723

3.  Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.

Authors:  A K Hodges; S Li; J Maynard; L Parry; R Braverman; J P Cheadle; J E DeClue; J R Sampson
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

4.  A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis.

Authors:  Daniel J Noonan; Dingyuan Lou; Nicole Griffith; Thomas C Vanaman
Journal:  Arch Biochem Biophys       Date:  2002-02-01       Impact factor: 4.013

5.  GABAergic interneuron development and function is modulated by the Tsc1 gene.

Authors:  Cary Fu; Bryan Cawthon; William Clinkscales; Adrienne Bruce; Peggy Winzenburger; Kevin C Ess
Journal:  Cereb Cortex       Date:  2011-10-20       Impact factor: 5.357

6.  Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252.

Authors:  A Balendran; R Currie; C G Armstrong; J Avruch; D R Alessi
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

7.  The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.

Authors:  G Benvenuto; S Li; S J Brown; R Braverman; W C Vass; J P Cheadle; D J Halley; J R Sampson; R Wienecke; J E DeClue
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

8.  A highly efficient recombineering-based method for generating conditional knockout mutations.

Authors:  Pentao Liu; Nancy A Jenkins; Neal G Copeland
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

9.  Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

Authors:  Erik J Uhlmann; Michael Wong; Rebecca L Baldwin; M Livia Bajenaru; Hiroaki Onda; David J Kwiatkowski; Kelvin Yamada; David H Gutmann
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

10.  Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage.

Authors:  Jessica A Gorski; Tiffany Talley; Mengsheng Qiu; Luis Puelles; John L R Rubenstein; Kevin R Jones
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  9 in total

1.  Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.

Authors:  Leslie S Gewin; Megan E Summers; Julie W Harral; Christa F Gaskill; Stellor Nlandu Khodo; Surekha Neelisetty; Timothy M Sullivan; Katharina Hopp; J Jeffrey Reese; Dwight J Klemm; Valentina Kon; Kevin C Ess; Wei Shi; Susan M Majka
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

2.  Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).

Authors:  Beth Crowell; Gum Hwa Lee; Ina Nikolaeva; Valentina Dal Pozzo; Gabriella D'Arcangelo
Journal:  eNeuro       Date:  2015-10-22

Review 3.  The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.

Authors:  Sean P Delaney; Lisa M Julian; William L Stanford
Journal:  Front Cell Dev Biol       Date:  2014-11-25

4.  Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement.

Authors:  Lawrence S Hsieh; John H Wen; Kumiko Claycomb; Yuegao Huang; Felicia A Harrsch; Janice R Naegele; Fahmeed Hyder; Gordon F Buchanan; Angelique Bordey
Journal:  Nat Commun       Date:  2016-06-01       Impact factor: 14.919

Review 5.  Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

Authors:  Juliana Magdalon; Sandra M Sánchez-Sánchez; Karina Griesi-Oliveira; Andréa L Sertié
Journal:  Int J Mol Sci       Date:  2017-03-18       Impact factor: 5.923

6.  Location-dependent maintenance of intrinsic susceptibility to mTORC1-driven tumorigenesis.

Authors:  Gabrielle V Rushing; Asa A Brockman; Madelyn K Bollig; Nalin Leelatian; Bret C Mobley; Jonathan M Irish; Kevin C Ess; Cary Fu; Rebecca A Ihrie
Journal:  Life Sci Alliance       Date:  2019-03-25

7.  Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.

Authors:  Robert P Carson; Nathaniel D Kelm; Kathryn L West; Mark D Does; Cary Fu; Grace Weaver; Eleanor McBrier; Brittany Parker; Mark D Grier; Kevin C Ess
Journal:  Ann Clin Transl Neurol       Date:  2015-10-27       Impact factor: 4.511

8.  P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development.

Authors:  Sarah Bowling; Aida Di Gregorio; Margarida Sancho; Sara Pozzi; Marieke Aarts; Massimo Signore; Michael D Schneider; Juan Pedro Martinez-Barbera; Jesús Gil; Tristan A Rodríguez
Journal:  Nat Commun       Date:  2018-05-02       Impact factor: 14.919

Review 9.  Effects of Mutations in TSC Genes on Neurodevelopment and Synaptic Transmission.

Authors:  Davide Bassetti; Heiko J Luhmann; Sergei Kirischuk
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.